OBJECTIVES The goal of this study was to compare the diagnostic accuracy of the coronary artery calcium score (CACS), coronary computed tomography angiography (CTA), single-photon emission computed tomography (SPECT), and a combination of these tools in the diagnosis of obstructive coronary artery disease (CAD) in patients with chronic kidney disease referred for cardiac evaluation before kidney transplantation.
Because the diagnostic accuracy of noninvasive stress testing is low, invasive coronary angiography (ICA) remains the gold standard for diagnosing obstructive CAD in kidney transplant candidates. ICA continues to be the preferred diagnostic tool in many institutions (4) despite the fact that the risk of complications is increased in patients with CKD.
The coronary artery calcium score (CACS), as assessed by using nonenhanced computed tomography, provides an absolute measure of coronary calcification, adds prognostic information, and correlates moderately with obstructive CAD (5, 6) . Coronary computed tomography angiography (CTA) is established as a noninvasive diagnostic test for stenosis in patients without CKD. Coronary CTA has been shown in several multicenter studies to have a high sensitivity (5,7). However, its specificity is not optimal due to false-positive results in patients with extensive coronary calcifications or high/irregular heart rates. These factors could be prevalent in kidney transplant candidates and affect the applicability of coronary CTA in this patient group. To our knowledge, no prospective studies have investigated the diagnostic accuracy of coronary CTA in patients with advanced CKD.
The combination of an anatomic test of stenosis (e.g., CACS or coronary CTA) and a functional stress evaluation of myocardial ischemia (e.g., SPECT) is known as cardiac hybrid imaging. This imaging has demonstrated improved sensitivity and specificity in patients with a high risk of CAD (8) . It is unknown whether this would also apply in patients with CKD.
The aim of the present study was to compare the accuracy of diagnosing obstructive CAD by using CACS, coronary CTA, SPECT, and a combination of these techniques (with ICA as the reference) in a large cohort of kidney transplantation candidates. was applied in all patients, with dose modulation in the systolic or diastolic phase depending on heart rate. Tube settings were dependent on patient weight, and current modulation was applied. Coronary images were reconstructed for every 5% of the cardiac cycle by using raw data iterative reconstruction. In relation to the cardiac scan, a high-pitch, low-dose flash scan was performed for evaluation of the aorta and iliac arteries using the same contrast injection. The contrast medium used was ioversol (350 mg/ml), and all patients received glyceryl nitrate (0.8 mg) sublingually before the CTTA. In addition, intravenous metoprolol was administered to obtain a heart rate of <65 beats/min to optimize coronary CTA images. the following manner: no stenosis: 0% diameter reduction (w0% area reduction); mild stenosis: 1% to 29% diameter reduction (w1% to 50% area reduction); moderate stenosis: 30% to 49% diameter reduction (w50% to 69% area reduction); and severe stenosis:
50% to 100% diameter reduction (w70% to 100% area reduction). Obstructive CAD was defined as a segment with a diameter >2 mm and a minimum 50% reduction in luminal diameter (w70% area reduction).
Nonevaluable segments with a diameter >2 mm were defined as having obstructive CAD. Coronary 
RESULTS
A total of 167 patients were studied. Twenty-nine patients were excluded because they did not complete the coronary CTA, SPECT, or ICA, leaving a final cohort of 138 patients ( Figure 1) . Baseline characteristics are summarized in (2%) patients ( Table 2) . Twenty patients had stenosis in a proximal coronary segment.
CORONARY ARTERY CALCIUM SCORE. The median Agatston CACS was 137 (interquartile range: 0 to 570).
The CACS was 0 in 35 (25%) patients and >400 in 45 (33%) patients ( Table 2 ). The prevalence of obstructive CAD was 0% and 44% in patients with CACS of 0 and >400, respectively. With a CACS threshold of 400, the sensitivity, specificity, PPV, and NPV for the detection of obstructive CAD defined according to ICA were 67% (95% CI: 47% to 83%), 77% (95% CI: 68% to 84%), 44%
(95% CI: 30% to 60%), and 89% (95% CI: 81% to 95%), respectively, in a patient-level model ( Figures 3A   and 4) . The PLR and NLR were 2.9 (95% CI: 1.9 to 4. in the distal right coronary artery and in the second diagonal branch ( Figure 3B ). The kappa value for the interobserver variability for coronary CTA was 0.71 (95% CI: 0.59 to 0.83).
The sensitivity, specificity, PPV, and NPV for diagnosing obstructive CAD were 93% (95% CI: 78% to 99%), 63% (95% CI: 53% to 72%), 41% (95% CI: 29 to 54), and 97% (95% CI: 90 to 100), respectively ( Figure 4 ).
The sensitivity of coronary CTA was higher (p < 0.01) and specificity was lower (p < 0.001) compared with CACS. The PLR and NLR were 2.5 (95% CI: 1.9 to 3.3) and 0.1 (95% CI: 0.0 to 0.4). The sensitivity for obstructive CAD in a proximal segment was 100% (95% CI: 83 to 100).
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY.
Myocardial stress was induced by adenosine in 127 (92%) patients, dobutamine in 3 (2%), and bicycle ergometer testing in 8 (6%). A total of 36 (26%) patients had an abnormal SPECT ( Table 2 ). The kappa value for interobserver variability according to SPECT was 0.72 (95% CI: 0.59 to 0.85).
The sensitivity, specificity, PPV, and NPV were 53% (95% CI: 34% to 72%), 82% (95% CI: 73% to 88%), 44%
(95% CI: 28% to 62%), and 86% (95% CI: 78% to 92%),
respectively. Comparing the diagnostic performance of SPECT versus CACS revealed no significant differences. Compared with coronary CTA, the sensitivity was lower (p < 0.01) and specificity was higher (p < 0.01) ( Figures 3C and 4) . PLR and NLR for SPECT were 2.9 (95% CI: 1.7 to 4.8) and 0.6 (95% CI: 0.4 to 0.8).
SPECT sensitivity for obstructive CAD in a proximal segment increased to 60% (95% CI: 36 to 81) compared with 53% (95% CI: 34 to 72) in the patient-level model.
HYBRID IMAGING. With the Hybrid (CACS/SPECT) modality, only 13 (9.4%) patients were categorized as abnormal according to the CACS threshold of 400.
The sensitivity, specificity, PPV, and NPV were 33% (95% CI: 17% to 53%), 97% (95% CI: 92% to 99%), 77%
(95% CI: 46% to 95%), and 84% (95% CI: 76% to 90%), respectively ( Figures 3D and 4) . The PLR and NLR The sensitivity, specificity, PPV, and NPV were 67% (95% CI: 47% to 83%), 86% (95% CI: 78% to 92%), 57%
(95% CI: 39% to 74%), and 90% (95% CI: 83% to 95%), respectively, in a patient-level model ( Figures 3E   and 4) . The PLR and NLR were 4.8 (95% CI: 2.8 to 8.2) and 0.4 (95% CI: 0.2 to 0.6).
Sensitivity was equal, but specificity was significantly higher with Hybrid (CACS/SPECT) compared with CACS. Compared with coronary CTA, the sensitivity was significantly lower, whereas specificity was significantly higher. Moreover, the sensitivity and specificity of Hybrid (coronary CTA/SPECT) were nonsignificantly higher than SPECT. PPV increased from 41% for coronary CTA and 44% for SPECT to 57%
for the combined Hybrid (coronary CTA/SPECT).
For proximal segments, the sensitivity for Hybrid (coronary CTA/SPECT) was 75% (95% CI: 51% to 91%). Values are n (%), median (interquartile range), or mean AE SD. *More than 1 pathologic finding was present in 6 patients.
CACS ¼ coronary artery calcium score; CTA ¼ computed tomography angiography; SPECT ¼ single-photon emission computed tomography.
FOLLOW-UP AND SAFETY. Acute renal failure. A total of 95 ml of contrast medium was used for the CTA of the coronary arteries, aorta, and iliac arteries.
For ICA, the mean contrast dose of medium was 52 AE 
DISCUSSION
The main finding in this study was that coronary CTA had a significantly higher sensitivity and NPV for diagnosing obstructive CAD but a lower specificity than CACS and SPECT. Hybrid imaging with coronary CTA and SPECT had a moderate sensitivity and a high specificity compared with SPECT or coronary CTA alone.
CACS AND CORONARY CTA. The pre-defined CACS threshold of 400 in this study had moderate diagnostic accuracy, equal to SPECT. This result is similar to that of Rosario et al. (9), who investigated the best CACS threshold for predicting obstructive CAD in 97 kidney transplantation candidates. The optimal CACS cutoff in this study was 187, yielding a sensitivity and specificity of 65% and 66%.
The applicability of coronary CTA before kidney transplantation was studied by Mao et al. (10) The reduced diagnostic performance of SPECT in patients with advanced CKD compared with the general population may be due to an impaired response to myocardial stress agents (16, 17) . In addition, false-negative results may be obtained in patients with severe CAD and balanced ischemia.
Finally, SPECT requires a substantial area of ischemia (10% of the myocardium) to be determined as positive, and it might not identify coronary stenosis in vessels supplying smaller territories. However, in our study, the sensitivity of SPECT was not substantially increased when only proximal stenosis was CLINICAL IMPLICATIONS. To date, only 1 randomized study has evaluated the benefit of coronary revascularization compared with medical treatment before kidney transplantation (19) . The study included patients with diabetes and was terminated prematurely due to a high number of events in the nonrevascularized study arm. However, data justifying a benefit of general cardiac evaluation before kidney transplantation are not available and might be difficult to achieve with the low sensitivity of the myocardial perfusion imaging techniques used in previous strategies. With a more exact diagnosis of CAD, it may be possible to optimize individualized medical treatment (e.g., statin, aspirin, beta-blockade therapy). In addition, careful perioperative management and coronary revascularization might also reduce morbidity and mortality.
We demonstrated that coronary CTA can be used 
